Biotech Holdings Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Holdings

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robin Peterson who wrote (18)	2/22/1997 10:50:00 AM
From: Robin Peterson	of 224

Hi Robin. Bought another 5000@$1.85 yesterday. Plan to buy more next week. The market is simply wrong on this stock. I now feel that having followed this company for this long, and knowing good news is not being released (although it is available), I'd rather be wrong by buying too much of a dud, than missing the chance to load up on a terrific story before the market does. The upside is so much greater than the downside, particularly for a company with earnings already, and all research costs already spent. The comparison that is starting to crop up is Amylin, which is a severe type II diabetes drug (smaller market than Diab II) although still in trials the stock is trading between US$10-15. The question is is BIO underpriced or will Amylin get hit as BIO's news comes out? Robin

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next